Published in Cancer Cytopathol on January 08, 2015
IgG4-related disease. N Engl J Med (2012) 15.76
Autoimmune pancreatitis. N Engl J Med (2006) 5.00
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol (2005) 4.10
A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87
Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology (2003) 3.86
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science (2011) 3.77
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature (2012) 3.51
Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am (2011) 3.23
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist (2011) 3.05
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum (2010) 2.90
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) (2012) 2.84
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer (2010) 2.81
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A (2012) 2.66
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol (2010) 2.56
Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med (2006) 2.46
Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys (2003) 2.36
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res (2011) 2.35
Reactive nodular fibrous pseudotumor of the gastrointestinal tract and mesentery: a clinicopathologic study of five cases. Am J Surg Pathol (2003) 2.35
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol (2007) 2.25
Case records of the Massachusetts General Hospital. Case 16-2008. A 46-year-old woman with bone pain. N Engl J Med (2008) 2.21
Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology (2009) 2.17
Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med (2014) 2.06
Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Am J Surg Pathol (2015) 2.02
Case records of the Massachusetts General Hospital. Case 33-2012. A 34-year-old woman with episodic paresthesias and altered mental status after childbirth. N Engl J Med (2012) 2.00
Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control (2005) 1.99
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94
False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer. Cancer (2003) 1.92
IgG4-related disease. Annu Rev Pathol (2013) 1.89
Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res (2012) 1.83
IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken) (2010) 1.83
Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res (2004) 1.80
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg (2011) 1.78
IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol (2011) 1.75
Infection in massive bone allografts. Clin Orthop Relat Res (2005) 1.73
Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol (2010) 1.69
Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) (2010) 1.65
Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol (2010) 1.61
Giant cell tumor of bone. J Am Acad Orthop Surg (2013) 1.59
Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol (2007) 1.53
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol (2012) 1.51
Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res (2004) 1.50
Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys (2006) 1.50
IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) (2013) 1.47
Gastrointestinal stromal tumors: an ultrastructural study. Int J Surg Pathol (2002) 1.45
Allografts about the Knee in Young Patients with High-Grade Sarcoma. Clin Orthop Relat Res (2004) 1.45
Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg (2012) 1.45
Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg (2007) 1.45
Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg (2008) 1.45
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma. Cancer (2014) 1.43
Survival data for patients with malignant schwannoma. Clin Orthop Relat Res (2004) 1.43
Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys (2007) 1.42
Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol (2010) 1.41
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med (2009) 1.41
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One (2009) 1.40
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg (2002) 1.39
MicroRNA Involvement in Osteosarcoma. Sarcoma (2012) 1.38
Metastatic myxoid liposarcomas: imaging and histopathologic findings. Skeletal Radiol (2007) 1.37
Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol (2002) 1.37
Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol (2008) 1.35
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clin Cancer Res (2014) 1.33
Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol (2008) 1.28
Epithelioid hemangioma of bone revisited: a study of 50 cases. Am J Surg Pathol (2009) 1.27
Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int (2004) 1.27
Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys (2008) 1.27
Unicameral bone cyst: a retrospective study of three surgical treatments. Clin Orthop Relat Res (2008) 1.27
Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol (2003) 1.25
Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One (2011) 1.24
Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol (2006) 1.23
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol (2008) 1.23
Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas (2011) 1.21
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J Clin Invest (2013) 1.21
Development of an IgG4-RD Responder Index. Int J Rheumatol (2012) 1.20
Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol (2010) 1.19
Long-term followup of proximal femoral allografts. Clin Orthop Relat Res (2002) 1.19
Split tolerance to a composite tissue allograft in a swine model. Transplantation (2003) 1.18
Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res (2003) 1.18
Bone cancer. J Natl Compr Canc Netw (2013) 1.17
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. Am J Surg Pathol (2014) 1.17
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg (2009) 1.17
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol (2014) 1.17
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems. Hum Pathol (2012) 1.16
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res (2010) 1.16
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One (2010) 1.16
Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res (2004) 1.15